21-14967968-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_003489.4(NRIP1):c.225G>A(p.Gly75Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.458 in 1,613,378 control chromosomes in the GnomAD database, including 176,315 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.53 ( 23322 hom., cov: 32)
Exomes 𝑓: 0.45 ( 152993 hom. )
Consequence
NRIP1
NM_003489.4 synonymous
NM_003489.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.974
Publications
46 publications found
Genes affected
NRIP1 (HGNC:8001): (nuclear receptor interacting protein 1) Nuclear receptor interacting protein 1 (NRIP1) is a nuclear protein that specifically interacts with the hormone-dependent activation domain AF2 of nuclear receptors. Also known as RIP140, this protein modulates transcriptional activity of the estrogen receptor. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 21-14967968-C-T is Benign according to our data. Variant chr21-14967968-C-T is described in ClinVar as Benign. ClinVar VariationId is 1326992.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.974 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.766 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.535 AC: 81200AN: 151870Hom.: 23296 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
81200
AN:
151870
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.502 AC: 125512AN: 249950 AF XY: 0.489 show subpopulations
GnomAD2 exomes
AF:
AC:
125512
AN:
249950
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.450 AC: 656994AN: 1461392Hom.: 152993 Cov.: 45 AF XY: 0.448 AC XY: 325433AN XY: 726962 show subpopulations
GnomAD4 exome
AF:
AC:
656994
AN:
1461392
Hom.:
Cov.:
45
AF XY:
AC XY:
325433
AN XY:
726962
show subpopulations
African (AFR)
AF:
AC:
24765
AN:
33476
American (AMR)
AF:
AC:
26684
AN:
44650
Ashkenazi Jewish (ASJ)
AF:
AC:
11080
AN:
26124
East Asian (EAS)
AF:
AC:
31752
AN:
39670
South Asian (SAS)
AF:
AC:
38658
AN:
86236
European-Finnish (FIN)
AF:
AC:
23526
AN:
53386
Middle Eastern (MID)
AF:
AC:
2501
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
470277
AN:
1111710
Other (OTH)
AF:
AC:
27751
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
20417
40834
61252
81669
102086
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
14656
29312
43968
58624
73280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.535 AC: 81280AN: 151986Hom.: 23322 Cov.: 32 AF XY: 0.537 AC XY: 39867AN XY: 74250 show subpopulations
GnomAD4 genome
AF:
AC:
81280
AN:
151986
Hom.:
Cov.:
32
AF XY:
AC XY:
39867
AN XY:
74250
show subpopulations
African (AFR)
AF:
AC:
30303
AN:
41478
American (AMR)
AF:
AC:
8544
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
1494
AN:
3472
East Asian (EAS)
AF:
AC:
4065
AN:
5168
South Asian (SAS)
AF:
AC:
2104
AN:
4812
European-Finnish (FIN)
AF:
AC:
4564
AN:
10540
Middle Eastern (MID)
AF:
AC:
137
AN:
292
European-Non Finnish (NFE)
AF:
AC:
28668
AN:
67938
Other (OTH)
AF:
AC:
1107
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1840
3681
5521
7362
9202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
690
1380
2070
2760
3450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2113
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Congenital anomalies of kidney and urinary tract 3 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.